115 related articles for article (PubMed ID: 29779936)
1. Early Response Assessment on Mid-treatment Computed Tomography Predicts for Locoregional Recurrence in Oropharyngeal Cancer Patients Treated With Definitive Radiation Therapy.
Kabarriti R; Brodin NP; Lundgren G; Ohri N; Tomé WA; Kalnicki S; Garg MK
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1036-1045. PubMed ID: 29779936
[TBL] [Abstract][Full Text] [Related]
2. Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer.
Lee H; Ahn YC; Oh D; Nam H; Kim YI; Park SY
Head Neck; 2014 Apr; 36(4):499-504. PubMed ID: 23780633
[TBL] [Abstract][Full Text] [Related]
3. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
Bar-Ad V; Wang ZX; Leiby B; Tuluc M
J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
[TBL] [Abstract][Full Text] [Related]
4. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
[TBL] [Abstract][Full Text] [Related]
5. Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study.
Söderström K; Nilsson P; Dalianis T; Kjellén E; Zackrisson B
Radiat Oncol; 2015 May; 10():117. PubMed ID: 26014350
[TBL] [Abstract][Full Text] [Related]
6. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
8. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
[TBL] [Abstract][Full Text] [Related]
9. Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Billfalk-Kelly A; Yu E; Su J; O'Sullivan B; Waldron J; Ringash J; Bartlett E; Perez-Ordonez B; Weinreb I; Bayley A; Bratman SV; Cho J; Giuliani M; Hope A; Hosni A; Kim J; Hansen AR; de Almeida J; Tong L; Xu W; Huang SH
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1017-1027. PubMed ID: 30953712
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of the tumor volume reduction rate in head-and-neck cancer during definitive intensity-modulated radiotherapy for organ preservation.
Yang SN; Liao CY; Chen SW; Liang JA; Tsai MH; Hua CH; Lin FJ
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1096-103. PubMed ID: 20605362
[TBL] [Abstract][Full Text] [Related]
11. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
12. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
[TBL] [Abstract][Full Text] [Related]
13. Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer.
Burr AR; Harari PM; Ko HC; Bruce JY; Kimple RJ; Witek ME
Oral Oncol; 2019 May; 92():52-56. PubMed ID: 31010623
[TBL] [Abstract][Full Text] [Related]
14. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
15. Adaptive Radiotherapy for Head and Neck Cancer.
Surucu M; Shah KK; Roeske JC; Choi M; Small W; Emami B
Technol Cancer Res Treat; 2017 Apr; 16(2):218-223. PubMed ID: 27502958
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
17. Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
Miller JA; Moradi F; Sundaram V; Liang R; Zhang C; Nguyen NK; Akhtar F; Liu Y; Ren Y; Harandi N; Weng Y; Pollom EL; Colevas AD; Divi V; Holsinger FC; Beadle BM; Le QT; Gensheimer MF
Head Neck; 2022 Nov; 44(11):2491-2504. PubMed ID: 35920790
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer.
Panje C; Riesterer O; Glanzmann C; Studer G
BMC Cancer; 2017 Sep; 17(1):643. PubMed ID: 28893236
[TBL] [Abstract][Full Text] [Related]
19. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?
Castelli J; Depeursinge A; de Bari B; Devillers A; de Crevoisier R; Bourhis J; Prior JO
Clin Nucl Med; 2017 Jun; 42(6):e281-e285. PubMed ID: 28288042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
